Dr. Rubsamen is a Board Certified anesthesiologist having received his medical training at Pacific Medical Center, San Francisco and Massachusetts General Hospital, where in 1989 he served as Chief Resident in Anesthesia. He was also a doctoral candidate in the computer science department at the Massachusetts Institute of Technology, leaving in 1990 to found Aradigm Corporation. He left Aradigm in 2000 to enter private practice and found Immunity Project. Dr. Rubsamen holds an A.B. in biochemistry and computer science from the University of California, Berkeley, and an M.S. in computer science and an M.D. from Stanford University. Dr. Rubsamen is a named inventor of more than 65 issued U.S. patents. Dr. Rubsamen is Director and CEO of Flow Pharma, Inc and the CEO and Co- Founder of Immunity Project.

Specialties:

-Board Certified Anesthesiologist

-Digital Signal Processing and Mixed Signal Engineer.

-Additional expertise in pharmaceutical chemistry, novel dosage form development and regulatory affairs leading to 510(k) and IND filings in the US as well as filings for clinical trials in the UK, Australia and the Netherlands.

Health, Global Health, Physician, Healthcare, Pharmaceutical, Inventors, Computer Science Technology,